{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T03:53:04Z","timestamp":1785815584889,"version":"3.56.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T00:00:00Z","timestamp":1670284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T00:00:00Z","timestamp":1670284800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1007\/s10147-022-02277-8","type":"journal-article","created":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T09:10:46Z","timestamp":1670317846000},"page":"299-305","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Clinical outcomes of intraductal carcinoma or cribriform in radical prostatectomy specimens of men opting for active surveillance: data from the PRIAS\u2013JAPAN study"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3884-8915","authenticated-orcid":false,"given":"Yoichiro","family":"Tohi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryou","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuma","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimpei","family":"Miyakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuji","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiichiro","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Mitsuzuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichi","family":"Inokuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Matsumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichiro","family":"Shiga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirohito","family":"Naito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Kohjimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihiko","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaharu","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidefumi","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Goto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reiji","family":"Haba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Kakehi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikio","family":"Sugimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,6]]},"reference":[{"key":"2277_CR1","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/j.eururo.2016.06.007","volume":"70","author":"LP Bokhorst","year":"2016","unstructured":"Bokhorst LP, Valdagni R, Rannikko A et al (2016) A decade of active surveillance in the PRIAS study: an update and evaluation of the criteria used to recommend a switch to active treatment. Eur Urol 70:954\u2013960","journal-title":"Eur Urol"},{"key":"2277_CR2","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.eururo.2019.12.017","volume":"77","author":"JJ Tosoian","year":"2020","unstructured":"Tosoian JJ, Mamawala M, Epstein JI et al (2020) Active surveillance of grade group 1 prostate cancer: long-term outcomes from a large prospective cohort. Eur Urol 77:675\u2013682","journal-title":"Eur Urol"},{"key":"2277_CR3","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1200\/JCO.2014.55.1192","volume":"33","author":"L Klotz","year":"2015","unstructured":"Klotz L, Vesprini D, Sethukavalan P et al (2015) Long-term follow-up of a large active surveillance cohort of patients with prostate cancer. J Clin Oncol 33:272\u2013277","journal-title":"J Clin Oncol"},{"key":"2277_CR4","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.eururo.2020.09.042","volume":"79","author":"N Mottet","year":"2021","unstructured":"Mottet N, van den Bergh RCN, Briers E et al (2021) EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer-2020 update. Part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol 79:243\u2013262","journal-title":"Eur Urol"},{"key":"2277_CR5","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1111\/bju.14935","volume":"125","author":"L Klotz","year":"2020","unstructured":"Klotz L (2020) Active surveillance in intermediate-risk prostate cancer. BJU Int 125:346\u2013354","journal-title":"BJU Int"},{"key":"2277_CR6","unstructured":"Network NCC NCCN clinical practice guidelines in oncology: Prostate cancer, version 2.2022"},{"key":"2277_CR7","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1016\/j.juro.2016.06.102","volume":"196","author":"HB Musunuru","year":"2016","unstructured":"Musunuru HB, Yamamoto T, Klotz L et al (2016) Active surveillance for intermediate risk prostate cancer: survival outcomes in the Sunnybrook experience. J Urol 196:1651\u20131658","journal-title":"J Urol"},{"key":"2277_CR8","doi-asserted-by":"publisher","first-page":"605.e1","DOI":"10.1016\/j.urolonc.2017.06.048","volume":"35","author":"R Savdie","year":"2017","unstructured":"Savdie R, Aning J, So AI et al (2017) Identifying intermediate-risk candidates for active surveillance of prostate cancer. Urol Oncol 35:605.e1-605.e8","journal-title":"Urol Oncol"},{"key":"2277_CR9","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.ejca.2016.07.012","volume":"66","author":"CF Kweldam","year":"2016","unstructured":"Kweldam CF, K\u00fcmmerlin IP, Nieboer D et al (2016) Prostate cancer outcomes of men with biopsy Gleason score 6 and 7 without cribriform or intraductal carcinoma. Eur J Cancer 66:26\u201333","journal-title":"Eur J Cancer"},{"key":"2277_CR10","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1002\/pros.22786","volume":"74","author":"K Kimura","year":"2014","unstructured":"Kimura K, Tsuzuki T, Kato M et al (2014) Prognostic value of intraductal carcinoma of the prostate in radical prostatectomy specimens. Prostate 74:680\u2013687","journal-title":"Prostate"},{"key":"2277_CR11","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1097\/PAS.0b013e3182a02169","volume":"37","author":"F Dong","year":"2013","unstructured":"Dong F, Yang P, Wang C et al (2013) Architectural heterogeneity and cribriform growth predict adverse clinical outcome for Gleason grade 4 prostatic adenocarcinoma. Am J Surg Pathol 37:1855\u20131861","journal-title":"Am J Surg Pathol"},{"key":"2277_CR12","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1007\/s10147-020-01841-4","volume":"26","author":"M Kato","year":"2021","unstructured":"Kato M, Hirakawa A, Sato H et al (2021) Grade group 2 (10% \u2265 GP4) patients have very similar malignant potential with grade group 1 patients, given the risk of intraductal carcinoma of the prostate. Int J Clin Oncol 26:764\u2013769","journal-title":"Int J Clin Oncol"},{"key":"2277_CR13","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1016\/j.eururo.2007.05.011","volume":"52","author":"RC van den Bergh","year":"2007","unstructured":"van den Bergh RC, Roemeling S, Roobol MJ et al (2007) Prospective validation of active surveillance in prostate cancer: the PRIAS study. Eur Urol 52:1560\u20131563","journal-title":"Eur Urol"},{"key":"2277_CR14","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1007\/s10147-020-01761-3","volume":"25","author":"Y Tohi","year":"2020","unstructured":"Tohi Y, Kato T, Matsumoto R et al (2020) The impact of complications after initial prostate biopsy on repeat protocol biopsy acceptance rate. Results from the prostate cancer research international: active surveillance JAPAN study. Int J Clin Oncol 25:2107\u20132114","journal-title":"Int J Clin Oncol"},{"key":"2277_CR15","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1007\/s10147-021-02041-4","volume":"27","author":"Y Tohi","year":"2022","unstructured":"Tohi Y, Kato T, Nakamura M et al (2022) Deferred radical prostatectomy in patients who initially elected for active surveillance: a multi-institutional, prospective, observational cohort of the PRIAS-JAPAN study. Int J Clin Oncol 27:194\u2013201","journal-title":"Int J Clin Oncol"},{"key":"2277_CR16","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyac092","author":"Y Tohi","year":"2022","unstructured":"Tohi Y, Kato T, Miyakawa J et al (2022) Impact of adherence to criteria on oncological outcomes of radical prostatectomy in patients opting for active surveillance: data from the PRIAS-JAPAN study. Jpn J Clin Oncol. https:\/\/doi.org\/10.1093\/jjco\/hyac092","journal-title":"Jpn J Clin Oncol"},{"key":"2277_CR17","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1097\/PAS.0000000000000530","volume":"40","author":"JI Epstein","year":"2016","unstructured":"Epstein JI, Egevad L, Amin MB et al (2016) The 2014 international society of urological pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma: definition of grading patterns and proposal for a new grading system. Am J Surg Pathol 40:244\u2013252","journal-title":"Am J Surg Pathol"},{"key":"2277_CR18","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1097\/00000478-199607000-00003","volume":"20","author":"JE McNeal","year":"1996","unstructured":"McNeal JE, Yemoto CEM (1996) Spread of adenocarcinoma within prostatic ducts and acini. Morphologic and clinical correlations. Am J Surg Pathol 20:802\u2013814","journal-title":"Am J Surg Pathol"},{"key":"2277_CR19","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.eururo.2015.09.032","volume":"69","author":"JJ Tosoian","year":"2016","unstructured":"Tosoian JJ, Sundi D, Trock BJ et al (2016) Pathologic outcomes in favorable-risk prostate cancer: comparative analysis of men electing active surveillance and immediate surgery. Eur Urol 69:576\u2013581. https:\/\/doi.org\/10.1016\/j.eururo.2015.09.032","journal-title":"Eur Urol"},{"key":"2277_CR20","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.juro.2018.04.078","volume":"200","author":"RA Godtman","year":"2018","unstructured":"Godtman RA, Schafferer M, Pihl CG et al (2018) Long-term outcomes after deferred radical prostatectomy in men initially treated with active surveillance. J Urol 200:779\u2013785. https:\/\/doi.org\/10.1016\/j.juro.2018.04.078","journal-title":"J Urol"},{"key":"2277_CR21","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1097\/JU.0000000000000247,30958738","volume":"202","author":"AS Balakrishnan","year":"2019","unstructured":"Balakrishnan AS, Cowan JE, Cooperberg MR et al (2019) Evaluating the safety of active surveillance: outcomes of deferred radical prostatectomy after an initial period of surveillance. J Urol 202:506\u2013510. https:\/\/doi.org\/10.1097\/JU.0000000000000247,30958738","journal-title":"J Urol"},{"key":"2277_CR22","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1007\/s00345-014-1453-8","volume":"33","author":"M Sugimoto","year":"2015","unstructured":"Sugimoto M, Hirama H, Yamaguchi A et al (2015) Should inclusion criteria for active surveillance for low-risk prostate cancer be more stringent? From an interim analysis of PRIAS-JAPAN. World J Urol 33:981\u2013987","journal-title":"World J Urol"},{"key":"2277_CR23","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1097\/JU.0000000000000526","volume":"203","author":"KJ Ericson","year":"2020","unstructured":"Ericson KJ, Wu SS, Lundy SD et al (2020) Diagnostic accuracy of prostate biopsy for detecting cribriform Gleason pattern 4 carcinoma and intraductal carcinoma in paired radical prostatectomy specimens: implications for active surveillance. J Urol 203:311\u2013319","journal-title":"J Urol"},{"key":"2277_CR24","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.juro.2017.07.037","volume":"199","author":"M Truong","year":"2018","unstructured":"Truong M, Feng C, Hollenberg G et al (2018) A comprehensive analysis of cribriform morphology on magnetic resonance imaging\/ultrasound fusion biopsy correlated with radical prostatectomy specimens. J Urol 199:106\u2013113","journal-title":"J Urol"},{"key":"2277_CR25","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.juro.2018.01.081","volume":"200","author":"S Prendeville","year":"2018","unstructured":"Prendeville S, Gertner M, Maganti M et al (2018) Role of magnetic resonance imaging targeted biopsy in detection of prostate cancer harboring adverse pathological features of intraductal carcinoma and invasive cribriform growth. J Urol 200:104\u2013113","journal-title":"J Urol"},{"key":"2277_CR26","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1016\/j.acra.2016.07.013","volume":"23","author":"MR Downes","year":"2016","unstructured":"Downes MR, Gibson E, Sykes J et al (2016) Determination of the association Between T2-weighted MRI and Gleason sub-pattern: a proof of principle study. Acad Radiol 23:1412\u20131421","journal-title":"Acad Radiol"},{"key":"2277_CR27","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1097\/PAS.0000000000001417","volume":"44","author":"JS Gandhi","year":"2020","unstructured":"Gandhi JS, Smith SC, Paner GP et al (2020) Reporting practices and resource utilization in the era of intraductal carcinoma of the prostate: a survey of genitourinary subspecialists. Am J Surg Pathol 44:673\u2013680","journal-title":"Am J Surg Pathol"},{"key":"2277_CR28","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.eururo.2019.12.009","volume":"77","author":"GT Chesnut","year":"2020","unstructured":"Chesnut GT, Vertosick EA, Benfante N et al (2020) Role of changes in magnetic resonance imaging or clinical stage in evaluation of disease progression for men with prostate cancer on active surveillance. Eur Urol 77:501\u2013507","journal-title":"Eur Urol"},{"key":"2277_CR29","doi-asserted-by":"publisher","first-page":"27","DOI":"10.4111\/icu.20210262","volume":"63","author":"NY Greenland","year":"2022","unstructured":"Greenland NY, Cooperberg MR, Wong AC et al (2022) Molecular risk classifier score and biochemical recurrence risk are associated with cribriform growth type in Gleason 3+4=7 prostate cancer. Investig Clin Urol 63:27\u201333","journal-title":"Investig Clin Urol"},{"key":"2277_CR30","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/j.euf.2017.11.010","volume":"5","author":"GA Sonn","year":"2019","unstructured":"Sonn GA, Fan RE, Ghanouni P et al (2019) Prostate magnetic resonance imaging interpretation varies substantially across radiologists. Eur Urol Focus 5:592\u2013599","journal-title":"Eur Urol Focus"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-022-02277-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10147-022-02277-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-022-02277-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T13:11:36Z","timestamp":1675170696000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10147-022-02277-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,6]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["2277"],"URL":"https:\/\/doi.org\/10.1007\/s10147-022-02277-8","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,6]]},"assertion":[{"value":"17 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing financial interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}